J Korean Med Assoc.  2010 May;53(5):386-391.

National Cancer Screening Program

• Nam JS

Abstract

Cancer is the most common cause of disease-related mortality in Korea and is the key target for the solution to promote the national health and stabilize the health insurance. Without the development of a definitive prevention or treatment method, the proportion of cancer-related mortality will further increase with the advent of aging society and transition of life pattern. Nationally-based cancer screening program has been expanded to cover a larger target population in Korea since 1999. Despite the existence of some flaw in the present cancer screening program between the participants and medical institutions, the number of people taking part in the cancer screening program has been increasing. With the reinforcement of the quality control and supervision, medical institutions participating in national cancer screening program can be expected to become well acquainted with related regulations and procedures. It is necessary for all parties involved to exercise a substantial effort to achieve health examiner's best satisfaction and the quality of the cancer screening program.

Keyword

Cancer screening program; Cancer

MeSH Terms

Aging
Early Detection of Cancer
Health Services Needs and Demand
Insurance, Health
Korea
Organization and Administration
Quality Control
Reinforcement (Psychology)
Social Control, Formal

Reference

1. Ministry of health and welfare. National cancer screening program. 2005.

2. National health insurance corporation. Practical guidelines of cancer screening program in 2010. 2010. 11–14.

3. Ministry of health and welfare. Operative guidelines of cancer screening program in 2010.

4. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Eng J Med. 1993. 328:1365–1371.

5. Seo HG. Screening for early detection of cancers II. J Korean Med Assoc. 2006. 6:515–530.

6. Yeun JM. Diagnosis and endoscopic treatment of gastric cancer. J Korean Med Assoc. 1992. 7:834–842.

7. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol. 2006. 12:4873–4874.

8. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993. 328:1365–1371.

9. Kwon JH, Choi MG, Suh JP, Chang JH, Nam KW, Park HS, Paik CN, Park JM, Cho YK, Lee IS, Kim SW, Chung IS. The Significance of fecal occult blood testing to screen for colon cancer. Korean J Gastrointest Endosc. 2007. 35:68–73.